RCI
BMY icon

RS Crum Inc’s Bristol-Myers Squibb BMY Stock Holding History

RS Crum Inc’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$398K Hold
6,570
– – 0.08% 71
2025
Q4 		$354K Hold
6,570
– – 0.07% 76
2025
Q3 		$296K Hold
6,570
– – 0.07% 81
2025
Q2 		$304K Hold
6,570
– – 0.07% 79
2025
Q1 		$401K Buy
6,570
+58
+0.9% +$3.38K 0.11% 60
2024
Q4 		$368K Hold
6,512
– – 0.09% 65
2024
Q3 		$337K Hold
6,512
– – 0.08% 75
2024
Q2 		$270K Hold
6,512
– – 0.07% 79
2024
Q1 		$353K Sell
6,512
-530
-8% -$27K 0.1% 59
2023
Q4 		$361K Hold
7,042
– – 0.11% 55
2023
Q3 		$409K Buy
+7,042
New +$431K 0.15% 49

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RS Crum Inc's BMY Position: Q1 2026 in Review

RS Crum Inc held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 6,570 shares worth $398K. The position accounts for 0.08% of the portfolio, ranked #71.

RS Crum Inc first reported a position in BMY in Q3 2023 and has held it in 11 quarters since. The position peaked at $409K in Q3 2023. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • RS Crum Inc held 6,570 shares of Bristol-Myers Squibb worth $398K as of Q1 2026.
  • RS Crum Inc left its Bristol-Myers Squibb share count unchanged in Q1 2026.
  • Bristol-Myers Squibb made up 0.08% of RS Crum Inc's portfolio in Q1 2026, its #71 holding.
  • RS Crum Inc first reported a position in Bristol-Myers Squibb in Q3 2023 and has held it in 11 quarters since.
  • RS Crum Inc's Bristol-Myers Squibb position peaked at $409K in Q3 2023.
  • 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on RS Crum Inc's 13F filing for Q1 2026, filed 15 Apr 2026.